Description
GLP-1 Peptide
This blend combines Cagrilintide, a long-acting amylin analog, with Semaglutide, a GLP-1 receptor agonist, studied together for their complementary appetite- and glucose-signaling pathways in metabolic research.
Specifications
| Composition | 5mg Cagrilintide · 5mg Semaglutide |
| Format | Lyophilized powder, single vial |
| Purity | ≥98% per component (HPLC verified) |
| Storage | -20°C lyophilized, protected from light and moisture; 2-8°C after reconstitution |
✓ Certificate of Analysis available for this production lot — view our testing process
In the Lab
Cagrilintide covers the amylin side of appetite signaling, Semaglutide covers GLP-1 — pairing them lets researchers study how those two hormone systems reinforce each other instead of testing either pathway on its own.
Reviews
There are no reviews yet.